Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial

Published:2005-01 Issue:1 Volume:257 Page:100-109
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

JAGER J.,KOOY A.,LEHERT Ph.,BETS D.,WULFFELE M. G.,TEERLINK T.,SCHEFFER P. G.,SCHALKWIJK C. G.,DONKER A. J. M.,STEHOUWER C. D. A.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.2004.01420.x/fullpdf

Reference50 articles.

1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

2. Atherosclerosis — An Inflammatory Disease

3. Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes

4. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.

5. Improved endothelial function with metformin in type 2 diabetes mellitus

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Protective Effect of Metformin in Type 2 Diabetes Patients;The Journal of Clinical Endocrinology & Metabolism;2024-07-11

2. Causal association of metformin treatment with diverse cardiovascular diseases: a Mendelian randomization analysis;Aging;2024-04-26

3. Exploring metformin monotherapy response in Type-2 diabetes: Computational insights through clinical, genomic, and proteomic markers using machine learning algorithms;Computers in Biology and Medicine;2024-03

4. Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease;Cells;2024-02-17

5. Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases;Pharmaceutics;2024-02-05